Essex Financial Services, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1315785
ESSEX, CT
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$417,253
+$83,242 QoQ
Shares Held
840
+12.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,125
of 1,735 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $1,755,786 across 7 Biotechnology names. VRTX ranks #1 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
840 | $417,253 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
644 | $401,559 | |
| 3 | INCY |
Incyte Corp
|
2,924 | $331,464 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
866 | $260,691 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,748 | $205,915 | |
| 6 | CRMD |
CorMedix Inc.
|
11,835 | $92,904 | |
| 7 | CGTX |
Cognition Therapeutics Inc
|
40,000 | $46,000 |
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $417,253 | 840 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $334,011 | 748 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $392,609 | 866 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $320,361 | 818 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $343,694 | 772 | Shares | Defined | 2025-07-16 | |
| 2025-03-31 | $376,705 | 777 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $322,562 | 801 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $444,616 | 956 | Shares | Defined | 2024-10-24 | |
| 2024-03-31 | $282,992 | 677 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $260,409 | 640 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $226,378 | 651 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $232,260 | 660 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $214,562 | 681 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $211,675 | 733 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $209,047 | 722 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $210,778 | 748 | Shares | Sole | 2022-08-01 | |
| No filing history on record for this holder in this stock. | ||||||